|
1
|
Atkins RC and Zimmet P: Diabetic kidney
disease: Act now or pay later. Kidney Int. 77:375–377. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper ME: Diabetes: Treating diabetic
nephropathy-still an unresolved issue. Nat Rev Endocrinol.
8:515–516. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reidy K, Kang HM, Hostetter T and Susztak
K: Molecular mechanisms of diabetic kidney disease. J Clin Invest.
124:2333–2340. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Badal SS and Danesh FR: New insights into
molecular mechanisms of diabetic kidney disease. Am J Kidney Dis.
63 2 Suppl 2:S63–S83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan Y, Li X, Xiao W, Fu J, Harris RC,
Lindenmeyer M, Cohen CD, Guillot N, Baron MH, Wang N, et al: BAMBI
elimination enhances alternative TGF-β signaling and glomerular
dysfunction in diabetic mice. Diabetes. 64:2220–2233. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du J, Hong S, Dong L, Cheng B, Lin L, Zhao
B, Chen YG and Chen X: Dynamic sialylation in transforming growth
factor-β (TGF-β)-induced epithelial to mesenchymal transition. J
Biol Chem. 290:12000–12013. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen KH, Hung CC, Hsu HH, Jing YH, Yang CW
and Chen JK: Resveratrol ameliorates early diabetic nephropathy
associated with suppression of augmented TGF-β/smad and ERK1/2
signaling in streptozotocin-induced diabetic rats. Chem Biol
Interact. 190:45–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Zhang Y, Zhu Z, Liu H, Guo H,
Xiong C, Xie K, Zhang X and Su S: Protective effect of berberine on
doxorubicin-induced acute hepatorenal toxicity in rats. Mol Med
Rep. 13:3953–3960. 2016.PubMed/NCBI
|
|
9
|
Adil M, Kandhare AD, Dalvi G, Ghosh P,
Venkata S, Raygude KS and Bodhankar SL: Ameliorative effect of
berberine against gentamicin-induced nephrotoxicity in rats via
attenuation of oxidative stress, inflammation, apoptosis and
mitochondrial dysfunction. Ren Fail. 38:996–1006. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Wang Z, Song Y, Wu D, Zheng X, Li
P, Jin J, Xu N and Li L: Effects of berberine on amelioration of
hyperglycemia and oxidative stress in high glucose and high fat
diet-induced diabetic hamsters in vivo. Biomed Res Int.
2015:3138082015.PubMed/NCBI
|
|
11
|
Zhang H, Li P, Burczynski FJ, Gong Y, Choy
P, Sha H and Li J: Attenuation of diabetic nephropathy in otsuka
long-evans tokushima fatty (OLETF) rats with a combination of
Chinese herbs (Tangshen Formula). Evid Based Complement Alternat
Med. 2011:6137372011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao TT, Zhang HJ, Lu XG, Huang XR, Zhang
WK, Wang H, Lan HY and Li P: Chaihuang-Yishen granule inhibits
diabetic kidney disease in rats through blocking TGF-β/Smad3
signaling. PLoS One. 9:e908072014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou CC, Wang W, Huang XR, Fu P, Chen TH,
Sheikh-Hamad D and Lan HY: Ultrasound-microbubble-mediated gene
transfer of inducible Smad7 blocks transforming growth factor-beta
signaling and fibrosis in rat remnant kidney. Am J Pathol.
166:761–771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu SF, Chang SY, Lee TC, Chuang LY, Guh
JY, Hung CY, Hung TJ, Hung YJ, Chen PY, Hsieh PF and Yang YL:
Dioscorea alata attenuates renal interstitial cellular fibrosis by
regulating Smad- and epithelial-mesenchymal transition signaling
pathways. PLoS One. 7:e474822012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Renno WM, Abdeen S, Alkhalaf M and Asfar
S: Effect of green tea on kidney tubules of diabetic rats. Br J
Nutr. 100:652–659. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo CW, Shen CJ, Tung YT, Chen HL, Chen
YH, Chang WH, Cheng KC, Yang SH and Chen CM: Extracellular
superoxide dismutase ameliorates streptozotocin-induced rat
diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Life
Sci. 135:77–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Liu H, Li N, Zhang Q and Zhang H:
The protective effect of fucoidan in rats with
streptozotocin-induced diabetic nephropathy. Mar Drugs.
12:3292–3306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mapanga RF, Tufts MA, Shode FO and
Musabayane CT: Renal effects of plant-derived oleanolic acid in
streptozotocin-induced diabetic rats. Ren Fail. 31:481–491. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodell CB, Rai R, Faubel S, Burdick JA and
Soranno DE: Local immunotherapy via delivery of interleukin-10 and
transforming growth factor β antagonist for treatment of chronic
kidney disease. J Control Release. 206:131–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Kim B, Park YK, Koo SI and Lee JY:
Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression
by inhibiting Smad3 activation in hepatic stellate cells. Biochim
Biophys Acta. 1850:178–185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Shi J, Li M, Gui B, Fu R, Yao G,
Duan Z, Lv Z, Yang Y, Chen Z, et al: Activation of AMPK by
metformin inhibits TGF-β-induced collagen production in mouse renal
fibroblasts. Life Sci. 127:59–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hinz B, Celetta G, Tomasek JJ, Gabbiani G
and Chaponnier C: Alpha-smooth muscle actin expression upregulates
fibroblast contractile activity. Mol Biol Cell. 12:2730–2741. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramos AM, González-Guerrero C, Sanz A,
Sanchez-Niño MD, Rodríguez-Osorio L, Martín-Cleary C,
Fernández-Fernández B, Ruiz-Ortega M and Ortiz A: Designing drugs
that combat kidney damage. Expert Opin Drug Discov. 10:541–556.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng XM, Tang PM, Li J and Lan HY:
TGF-β/Smad signaling in renal fibrosis. Front Physiol. 6:822015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng LQ, Tang JW, Wang Y, Zhao JR, Shang
MY, Zhang M, Liu SY, Qu L, Cai SQ and Li XM: Astragaloside IV
synergizes with ferulic acid to inhibit renal tubulointerstitial
fibrosis in rats with obstructive nephropathy. Br J Pharmacol.
162:1805–1818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao J, Kong W and Jiang J: Learning from
berberine: Treating chronic diseases through multiple targets. Sci
China Life Sci. 58:854–859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh IP and Mahajan S: Berberine and its
derivatives: A patent review (2009–2012). Expert Opin Ther Pat.
23:215–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
